carbostyril has been researched along with Torsade de Pointes in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 6 (60.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Corti, N; Hoppe, L; Kovari, H; Maechler, S; Niedrig, D; Russmann, S | 1 |
Arbel, Y; Henis, O; Justo, D; Mashav, N; Paran, Y; Swartzon, M | 1 |
Bauer, LK; Januzzi, JL; Leskov, I; Mukherji, EH; Tanev, KS | 1 |
Leung, JG; Nelson, S | 1 |
Akita, M; Hiratsuka, K; Izumi, M; Kurosawa, T; Sakai, T; Shibazaki, Y; Shindo, Y | 1 |
Owens, RC | 1 |
Citrome, L; Volavka, J | 1 |
Breithardt, G; Cakir, Y; Eckardt, L; Engelen, MA; Haverkamp, W; Hilker, E; Milberg, P; Mönnig, G; Osada, N; Ramtin, S; Stypmann, J | 1 |
Hondeghem, LM | 1 |
Dupont, H; Gachot, B; Regnier, B; Souweine, B; Timsit, JF; Wolff, M | 1 |
3 review(s) available for carbostyril and Torsade de Pointes
Article | Year |
---|---|
Drug-induced torsades de pointes in patients aged 80 years or more.
Topics: Aged, 80 and over; Female; Humans; Long QT Syndrome; Macrolides; Male; Quinolones; Risk Factors; Sex Factors; Torsades de Pointes | 2008 |
QT prolongation with antimicrobial agents: understanding the significance.
Topics: Animals; Anti-Infective Agents; Humans; Long QT Syndrome; Macrolides; Product Surveillance, Postmarketing; Quinolones; Randomized Controlled Trials as Topic; Risk Factors; Torsades de Pointes | 2004 |
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain | 2004 |
7 other study(ies) available for carbostyril and Torsade de Pointes
Article | Year |
---|---|
Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Atorvastatin; Clonidine; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Humans; Long QT Syndrome; Macrolides; Male; Medication Errors; Middle Aged; Quinolones; Risk Factors; Simvastatin; Tertiary Care Centers; Torsades de Pointes; Young Adult | 2016 |
Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Bundle-Branch Block; Combined Modality Therapy; Cooperative Behavior; Electrocardiography; Electroconvulsive Therapy; Female; Haloperidol; Humans; Interdisciplinary Communication; Long QT Syndrome; Piperazines; Quinolones; Risk Factors; Torsades de Pointes | 2011 |
Torsades de pointes after administration of low-dose aripiprazole.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Diabetes Complications; Drug Monitoring; Heart Arrest; Humans; Hypertension; Male; Piperazines; Quinolones; Risk Factors; Schizophrenia; Stroke; Torsades de Pointes; Treatment Outcome | 2013 |
Comparative assessment of prurifloxacin, sparfloxacin, gatifloxacin and levofloxacin in the rabbit model of proarrhythmia.
Topics: Animals; Anti-Infective Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Long QT Syndrome; Male; Quinolones; Rabbits; Torsades de Pointes | 2004 |
Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
Topics: Action Potentials; Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Fluoroquinolones; Heart Conduction System; In Vitro Techniques; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Rabbits; Torsades de Pointes | 2007 |
Relative contributions of TRIaD and QT to proarrhythmia.
Topics: Action Potentials; Animals; Anti-Infective Agents; Dose-Response Relationship, Drug; Heart Conduction System; Humans; Quinolones; Rabbits; Torsades de Pointes | 2007 |
Torsades de pointe probably related to sparfloxacin.
Topics: Anti-Infective Agents; Female; Fluoroquinolones; Humans; Mastoiditis; Middle Aged; Otitis Media; Pneumococcal Infections; Quinolones; Torsades de Pointes | 1996 |